HPTN 027
A Phase I Study to Evaluate the Safety and Immunogenicity of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda
Study DocumentsProtocol
Study-Specific Procedures Manual
|
Study DocumentsProtocol
Study-Specific Procedures Manual
|